Table 3.
Prospective comparisons between participants diagnosed with HbA1c < 48 mmol/mol and those diagnosed with HbA1c ≥ 48 mmol/mol at year 1.
| n with data | HbA1c < 48 mmol/mol (6.5%) | HbA1c ≥ 48 mmol/mol (6.5%) | p value | |
|---|---|---|---|---|
| Median (IQR) HbA1c at year 1 | ||||
| HbA1c (mmol/mol) | 1251 | 43.17 (40.98–47.54), | 49.72 (45.35–57.37) | <0.0001 |
| HbA1c (%) | 6.10 (5.90–6.50) | 6.70 (6.30–7.40), | ||
|
| ||||
| New complication status at year 1 | ||||
| Retinopathy (%) | 1220 | 32 (10.88) | 126 (13.61) | 0.2257 |
| Microalbuminuria (%) | 1025 | 22 (9.21) | 123 (15.65) | 0.0123 |
| MI (%) | 1278 | 10 (3.38) | 12 (1.22) | 0.0124 |
| Stroke (%) | 1272 | 4 (1.4) | 7 (0.72) | 0.2951 |
|
| ||||
| Cumulative microalbuminuria and MI status at year 1 | ||||
| Microalbuminuria (%) | 1218 | 39 (14.77) | 191 (20.02) | 0.0540 |
| MI (%) | 1487 | 29 (8.55) | 59 (5.14) | 0.0190 |
|
| ||||
| Medication status at year 1 | ||||
| Receiving oral agents (%) | 1296 | 92 (30.6) | 715 (71.9) | <0.0001 |
| Receiving insulin (%) | 1294 | 8 (2.67) | 37 (3.72) | 0.3817 |
|
| ||||
| Cardiovascular risk factor status (SD) at year 1 | ||||
| BMI (kg/m2) | 1308 | 31.28 (±6.44) | 32.14 (±6.35) | 0.0400 |
| BPD (mmHg) | 1282 | 80.21 (±10.76) | 82.22 (±10.91) | 0.0057 |
| BPS (mmHg) | 1284 | 135.42 (±18.28) | 134.57 (±17.23) | 0.4614 |
| LDL-C (mmol/L) | 1164 | 2.49 (±0.80) | 2.51 (±0.84) | 0.7485 |
| HDL-C (mmol/L) | 1200 | 1.32 (±0.48) | 1.25 (±0.34) | 0.0081 |
| Total cholesterol (mmol/L) | 1234 | 4.40 (±1.30) | 4.40 (±1.20) | 0.0942 |
| Triglycerides (mmol/L) | 1164 | 2.49 (±0.80) | 2.51 (±0.84) | 0.5454 |
| Smoking status (%) | 1149 | 190 (21.62) | 41 (15.19) | 0.0211 |